NFKB1 and atherosclerosis: In an atherosclerosis-prone animal model, increased LPS levels, as a marker of gut dysbiosis, potentiated the progression of atherosclerotic plaques and promoted the proliferation of vascular smooth muscle cells via osteopontin production by monocytes in an NF-κB dependent manner.